BRAFV600E突变与美国放射学会甲状腺影像报告和数据系统及临床病理特征的关联:儿童甲状腺乳头状癌患者
回顾性评估2013年5月至2023年5月接受甲状腺切除术的儿童甲状腺乳头状癌患者,BRAFV600E突变见于59.1%(39/66)。多因素分析显示低回声/极低回声(OR=8.48)和点状强回声灶(OR=24.3)是与BRAFV600E突变相关的独立因素,BRAFV600E突变与TI-RADS 5显著相关(OR=12.61)。联合低回声/极低回声和点状强回声灶预测BRAFV600E突变的敏感度、特异度、阳性预测值、阴性预测值和准确率分别为89.7%、85.2%、89.7%、85.2%和87.9%。
要点
- 儿童甲状腺乳头状癌中BRAFV600E突变率为59.1%(39/66)。
- 低回声/极低回声和点状强回声灶是与BRAFV600E突变相关的独立因素。
- TI-RADS 5与BRAFV600E突变显著相关(OR=12.61,95%CI 1.28-124.49,P=0.03)。
核心结论
- 低回声/极低回声、点状强回声灶和TI-RADS 5与儿童甲状腺乳头状癌患者BRAFV600E突变独立相关。
研究设计与样本
- 回顾性评估2013年5月至2023年5月接受甲状腺切除术的儿童甲状腺乳头状癌患者,采用单因素和多因素logistic回归分析,评估TI-RADS预测BRAFV600E突变的诊断性能。
关键影像表现/征象
- 低回声/极低回声与BRAFV600E突变独立相关(OR=8.48,95%CI 1.48-48.74,P=0.02)。
- 点状强回声灶与BRAFV600E突变独立相关(OR=24.3,95%CI 3.80-155.84,P=0.001)。
- TI-RADS 5与BRAFV600E突变显著相关(OR=12.61,95%CI 1.28-124.49,P=0.03)。
- BRAFV600E突变与结节大小、成分、形态、边缘、颈部淋巴结转移或桥本甲状腺炎无关联(P>0.05)。
诊断标准与关键数值
- 联合低回声/极低回声和点状强回声灶预测BRAFV600E突变:敏感度89.7%,特异度85.2%,阳性预测值89.7%,阴性预测值85.2%,准确率87.9%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Identifying the associations between BRAFV600E mutation, the American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) and clinicopathological characteristics could assist in making appropriate treatment strategies for pediatric patients with papillary thyroid carcinoma.
OBJECTIVE: To retrospectively assess the associations between BRAFV600E mutation, TI-RADS, and clinicopathological characteristics in pediatric patients with papillary thyroid carcinoma.
MATERIALS AND METHODS: Between May 2013 and May 2023, pediatric patients with papillary thyroid carcinoma who underwent thyroidectomy were retrospectively evaluated. Univariate and multivariate logistic regression analyses were performed to determine the associations between BRAFV600E mutation, TI-RADS, and clinicopathological characteristics. The diagnostic performance of TI-RADS to predict BRAFV600E mutation was assessed.
RESULTS: The BRAFV600E mutation was found in 59.1% (39/66) of pediatric patients with papillary thyroid carcinoma. Multivariate analyses showed that hypoechoic/very hypoechoic [odds ratio (OR) = 8.48; 95% confidence interval (CI) = 1.48-48.74); P-value = 0.02] and punctate echogenic foci (OR = 24.3; 95% CI = 3.80-155.84; P-value = 0.001) were independent factors associated with BRAFV600E mutation. In addition, BRAFV600E mutation was significantly associated with TI-RADS 5 (OR = 12.61; 95% CI = 1.28-124.49; P-value = 0.03). There were no associations between BRAFV600E mutation and nodule size, composition, shape, margin, cervical lymph node metastasis, or Hashimoto's thyroiditis (P-value > 0.05). Combined with hypoechoic/very hypoechoic and punctate echogenic foci, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 89.7%, 85.2%, 89.7%, 85.2%, and 87.9%, respectively.
CONCLUSIONS: Hypoechoic/very hypoechoic, punctate echogenic foci, and TI-RADS 5 are independently associated with BRAFV600E mutation in pediatric patients with papillary thyroid carcinoma.
引用
- Tan Y, Zhong J, Zheng T, et al. Associations of BRAFV600E mutation with the American College of Radiology Thyroid Imaging Reporting and Data System and clinicopathological characteristics in pediatric patients with papillary thyroid carcinoma. Pediatr Radiol. 2024. PMID: 38771344. doi:10.1007/s00247-024-05943-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。